Form 4: Elutia Inc. CFO Matthew Ferguson Reports Stock Transactions Following Vesting of Restricted Stock Units
SEC Form 4 Filing
Elutia Inc.'s Chief Financial Officer, Matthew Ferguson, reported the acquisition of 12,500 shares of Class A Common Stock and the disposal of 4,461 shares to cover tax obligations, following the vesting of restricted stock units.
Summary
- Matthew Ferguson, the Chief Financial Officer of Elutia Inc., reported transactions related to the vesting of restricted stock units.
- On December 10, 2024, 12,500 shares of Class A Common Stock were acquired due to the vesting of restricted stock units.
- Also on December 10, 2024, 4,461 shares were disposed of to cover tax withholding requirements at a price of $4.29 per share.
- Following these transactions, Mr. Ferguson beneficially owns 318,744 shares of Class A Common Stock directly.
- Mr. Ferguson also holds 100,000 restricted stock units.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The transactions are routine and expected, indicating normal business operations. The vesting of stock units suggests that performance targets are being met.
Positives
- The vesting of restricted stock units indicates that performance milestones were likely met.
- The acquisition of shares increases Mr. Ferguson's direct stake in the company.
Negatives
- The disposal of shares to cover tax obligations reduces the total number of shares held by Mr. Ferguson.
Risks
- The sale of shares to cover tax obligations could be perceived negatively by some investors, although it is a common practice.
- Fluctuations in the stock price could impact the value of Mr. Ferguson's holdings.
Industry Context
This is a standard SEC Form 4 filing, which is a routine disclosure for company insiders when they trade company stock. It is common for executives to receive stock-based compensation, and the vesting of these units is a regular occurrence.
Comparison to Industry Standards
- Stock-based compensation is a common practice across many industries, particularly in technology and biotech, to align the interests of management with those of shareholders.
- The vesting schedule of restricted stock units, with quarterly vesting over several years, is also a typical approach to incentivize long-term performance.
- Companies like Amgen, Gilead Sciences, and Regeneron Pharmaceuticals also use similar stock-based compensation plans for their executives.
Stakeholder Impact
- The transactions have a minor impact on shareholders, as they are related to executive compensation and do not significantly alter the company's capital structure.
- The vesting of stock units can be seen as a positive sign for employees, as it indicates that performance goals are being achieved.
Key Dates
| Date | Description |
|---|---|
| 01/31/2024 | Matthew Ferguson was granted 150,000 restricted stock units. |
| 06/10/2024 | 1/6 of the restricted stock units vested. |
| 09/10/2024 | 1/12 of the restricted stock units vested. |
| 12/10/2024 | 1/12 of the restricted stock units vested, resulting in the reported transactions. |
| 03/10/2025 | 1/12 of the restricted stock units will vest. |
| 06/10/2025 | 1/12 of the restricted stock units will vest. |
| 09/10/2025 | 1/12 of the restricted stock units will vest. |
| 12/10/2025 | 1/12 of the restricted stock units will vest. |
| 03/10/2026 | 1/12 of the restricted stock units will vest. |
| 06/10/2026 | 1/12 of the restricted stock units will vest. |
| 09/10/2026 | 1/12 of the restricted stock units will vest. |
| 12/10/2026 | 1/12 of the restricted stock units will vest. |
| 12/11/2024 | Date of the report filing. |
Keywords
Elutia Inc, Matthew Ferguson, restricted stock units, Class A Common Stock, insider trading, SEC Form 4, vesting, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.